Use of glucosamine and chondroitin supplements and risk of colorectal cancer

33Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose Glucosamine and chondroitin are non-vitamin, non-mineral supplements which have anti-inflammatory properties. These supplements are typically used for joint pain and osteoarthritis and are commonly taken as either glucosamine alone or glucosamine plus chondroitin. An exploratory analysis conducted within the VITamins And Lifestyle (VITAL) study observed any use of glucosamine and chondroitin to be associated with reduced risk of colorectal cancer (CRC) after 5 years of follow-up. Methods With two additional years of follow-up, we have studied these associations in greater depth, including associations by frequency/duration of use and by formulation, and have evaluated whether observed associations are modified by factors associated with inflammation. Participants include 75,137 western Washington residents aged 50-76 who completed the mailed VITAL questionnaire between 2000 and 2002. Use of glucosamine and chondroitin was ascertained by questions about supplement use during the 10-year period prior to baseline, and participants were followed for CRC through 2008 (n = 557). Cox regression was used to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs). Results Persons reporting use of glucosamine ? chondroitin on 4? days/week for 3? years had a non-statistically significant 45 %lower CRC risk than non-users (HR: 0.55; 95 % CI 0.30-1.01; p-Trend: 0.16). This association varied by body mass index (p-interaction: 0.006), with inverse association observed among the overweight/obese (p-Trend: 0.02), but not among the underweight/normal weight. Use of glucosamine alone was not significantly associated with CRC risk. Conclusions There is great need to identify safe and effective cancer preventive strategies, suggesting that glucosamine and chondroitin may merit further attention as a potential chemopreventive agent. © 2013 Springer Science+Business Media Dordrecht.

Cite

CITATION STYLE

APA

Kantor, E. D., Lampe, J. W., Peters, U., Shen, D. D., Vaughan, T. L., & White, E. (2013). Use of glucosamine and chondroitin supplements and risk of colorectal cancer. Cancer Causes and Control, 24(6), 1137–1146. https://doi.org/10.1007/s10552-013-0192-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free